Bone loss with exemestane: Is the jury still out?
Cheung
Angela M
AM
Tomlinson
George
G
Goss
Paul E
PE
D000730:Androstadienes / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects*; D001943:Breast Neoplasms; D005260:Female; D005269:Femur; D006801:Humans; D017698:Postmenopause; D015203:Reproducibility of Results
D000730:Androstadienes; D000970:Antineoplastic Agents; C056516:exemestane